AIRLINK 212.82 Increased By ▲ 3.27 (1.56%)
BOP 10.25 Decreased By ▼ -0.21 (-2.01%)
CNERGY 7.00 Decreased By ▼ -0.35 (-4.76%)
FCCL 33.47 Decreased By ▼ -0.92 (-2.68%)
FFL 17.64 Decreased By ▼ -0.41 (-2.27%)
FLYNG 21.82 Decreased By ▼ -1.10 (-4.8%)
HUBC 129.11 Decreased By ▼ -3.38 (-2.55%)
HUMNL 13.86 Decreased By ▼ -0.28 (-1.98%)
KEL 4.86 Decreased By ▼ -0.17 (-3.38%)
KOSM 6.93 Decreased By ▼ -0.14 (-1.98%)
MLCF 43.63 Decreased By ▼ -1.57 (-3.47%)
OGDC 212.95 Decreased By ▼ -5.43 (-2.49%)
PACE 7.22 Decreased By ▼ -0.36 (-4.75%)
PAEL 41.17 Decreased By ▼ -0.53 (-1.27%)
PIAHCLA 16.83 Decreased By ▼ -0.47 (-2.72%)
PIBTL 8.63 Increased By ▲ 0.08 (0.94%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 183.03 Decreased By ▼ -6.00 (-3.17%)
PRL 39.63 Decreased By ▼ -2.70 (-6.38%)
PTC 24.73 Decreased By ▼ -0.44 (-1.75%)
SEARL 98.01 Decreased By ▼ -5.95 (-5.72%)
SILK 1.01 Decreased By ▼ -0.02 (-1.94%)
SSGC 41.73 Increased By ▲ 2.49 (6.35%)
SYM 18.86 Decreased By ▼ -0.30 (-1.57%)
TELE 9.00 Decreased By ▼ -0.24 (-2.6%)
TPLP 12.40 Decreased By ▼ -0.70 (-5.34%)
TRG 65.68 Decreased By ▼ -3.50 (-5.06%)
WAVESAPP 10.98 Increased By ▲ 0.26 (2.43%)
WTL 1.79 Increased By ▲ 0.08 (4.68%)
YOUW 4.03 Decreased By ▼ -0.11 (-2.66%)
BR100 11,866 Decreased By -213.1 (-1.76%)
BR30 35,697 Decreased By -905.3 (-2.47%)
KSE100 114,148 Decreased By -1904.2 (-1.64%)
KSE30 35,952 Decreased By -625.5 (-1.71%)

In a major breakthrough, scientists announced on November 20 they have generated stem cells from human skin which could help in the fight against major diseases and side-step the battle over using embryonic cells.
The discovery opens the door for promising research into using the blank-slate stem cells to test new drugs and study how diseases function without being forced to destroy embryos in the process, which has led to legal restrictions on research in the United States.
The researchers in Japan and the United States have also eliminated a major hurdle to using stem cells in treatments. The stem cells could eventually be generated with a specific patient's genetic code, eliminating the risk that the body would reject transplanted tissues or organs.
The new method is expected to rapidly advance research in the treatment of cancer, Alzheimer's and Parkinson's diseases, diabetes, arthritis, spinal cord injuries, strokes, burns and heart disease because scientists will have much greater access to stem cells.
"The work is monumental in its importance to the field of stem cell science and its potential impact on our ability to accelerate the benefits of this technology to the bedside," said Deepak Srivastava, director of the Gladstone Institute of Cardiovascular Disease.
"Not only does this discovery enable more research, it offers a new pathway to apply the benefits of stem cells to human disease."
Stem cells are seen as a possible magic bullet because they can be developed into any of the 220 types of cells in the human body. But research has been limited in the United States because of ethical concerns, and very few labs have had the resources and technical expertise to work with embryonic stem cells.
The new method is fairly straightforward and can be repeated by standard labs with relative ease, said study author James Thomson of the University of Wisconsin at Madison.
"My personal barometer of optimism has gone up a lot," Thomson said in a conference call. "Funding is finally going to go up because this does remove the political debate. And as we engage more and more people in the United States things are going to accelerate."
The White House hailed the discovery as a means of solving medical problems "without compromising either the high aims of science or the sanctity of human life." Two teams of researchers were simultaneously able to transform the skin cells by using a retrovirus to insert four different genes into the cells.
The Japanese team, led by Shinya Yamanaka of Kyoto University, managed to produce one stem cell line out of every 5,000 cells.

Copyright Agence France-Presse, 2007

Comments

Comments are closed.